XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheet - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 553 $ 264
Short-term investments   4
Accounts receivable, net 913 977
Inventories 908 861
Prepaid expenses 56 54
Total current assets 2,430 2,160
Property, plant and equipment, net of accumulated depreciation of $3,087 and $3,056, respectively 2,354 2,306
Goodwill 841 801
Other intangible assets, net of accumulated amortization of $220 and $197, respectively 479 437
Operating lease assets 161 151
Deferred income tax assets 23 13
Other assets 176 172
Total assets 6,464 6,040
Current liabilities:    
Short-term borrowings 62 82
Accounts payable and accrued liabilities 893 885
Total current liabilities 955 967
Non-current liabilities 211 220
Long-term debt 2,115 1,766
Non-current operating lease liabilities 123 120
Deferred income tax liabilities 189 195
Total liabilities 3,593 3,268
Share-based payments subject to redemption 32 31
Redeemable non-controlling interests 74  
Ingredion stockholders' equity:    
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at September 30, 2020 and December 31, 2019, respectively 1 1
Additional paid-in capital 1,145 1,137
Less: Treasury stock (common stock: 10,822,592 and 10,993,388 shares at September 30, 2020 and December 31, 2019, respectively) at cost (1,027) (1,040)
Accumulated other comprehensive loss (1,259) (1,158)
Retained earnings 3,884 3,780
Total Ingredion stockholders' equity 2,744 2,720
Non-redeemable non-controlling interests 21 21
Total equity 2,765 2,741
Total liabilities and equity $ 6,464 $ 6,040